Cargando…
Short-term outcomes of mirogabalin in patients with peripheral neuropathic pain: a retrospective study
BACKGROUND: Mirogabalin, which is approved for the treatment of peripheral neuropathic pain in Japan, is a ligand for the α2δ subunit of voltage-gated calcium channels. Both pregabalin and mirogabalin act as nonselective ligands at the α2δ-1 and α2δ-2 subunits. Mirogabalin has a unique binding profi...
Autores principales: | Tetsunaga, Tomoko, Tetsunaga, Tomonori, Nishida, Keiichiro, Misawa, Haruo, Takigawa, Tomoyuki, Yamane, Kentaro, Tsuji, Hironori, Takei, Yoshitaka, Ozaki, Toshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249688/ https://www.ncbi.nlm.nih.gov/pubmed/32456647 http://dx.doi.org/10.1186/s13018-020-01709-3 |
Ejemplares similares
-
The factors driving self-efficacy in intractable chronic pain patients: a retrospective study
por: Tsuji, Hironori, et al.
Publicado: (2019) -
Drug dependence in patients with chronic pain: A retrospective study
por: Tetsunaga, Tomoko, et al.
Publicado: (2018) -
Quantification of patellar tendon reflex using portable mechanomyography and electromyography devices
por: Tsuji, Hironori, et al.
Publicado: (2021) -
Factors influencing caregiver burden in chronic pain patients: A retrospective study
por: Tsuji, Hironori, et al.
Publicado: (2022) -
Evaluation of SARC-F and SARC-CalF for sarcopenia screening in patients with chronic musculoskeletal pain: A prospective cross-sectional study
por: Tsuji, Hironori, et al.
Publicado: (2022)